Effectiveness, treatment completion and safety of sofosbuvir/ledipasvir and paritaprevir/ritonavir/ombitasvir + dasabuvir in patients with chronic kidney disease: an ERCHIVES study

Alimentary Pharmacology&Therapeutics, EarlyView.

Source: Alimentary Pharmacology and Therapeutics - May 24, 2018 Category: Drugs & Pharmacology Authors: A. A. Butt , Y. Ren , A. Puenpatom , J. M. Arduino , R. Kumar , A ‐B. Abou‐Samra Source Type: research